Home Stock

Stock Research: Redcare Pharmacy

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Redcare Pharmacy

GER:RDC NL0012044747
42
  • Value
    98
  • Growth
    41
  • Safety
    Safety
    34
  • Combined
    77
  • Sentiment
    29
  • 360° View
    360° View
    42
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Redcare Pharmacy NV is an online retailer of pharmaceutical products. The company focuses on non-prescription medication (OTC), and pharmacy-related beauty and personal care (BPC) products. It operates in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany. In the last fiscal year, the company had $2,189 million market cap, $565 million profits, $2,454 million revenue and 2659 employees.

more

ANALYSIS: With an Obermatt 360° View of 42 (better than 42% compared with alternatives), overall professional sentiment and financial characteristics for the stock Redcare Pharmacy are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Redcare Pharmacy. Only the consolidated Value Rank has an attractive rank of 98, which means that the share price of Redcare Pharmacy is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 98% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 41, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 34, meaning the company has a riskier financing structure than 66% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 71% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 29. ...read more

more
Strongest Rank Profit Growth
Weakest Rank Price vs. Earnings (P/E)
Country Netherlands
Industry Drug Retail
Size Medium
Website redcare-pharmacy.com
Index
MDAX
Sound Pay Europe
Redcare Pharmacy stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
98 8 8 25
Growth
41 59 100 31
Safety
Safety
34 40 29 82
Sentiment
29 49 55 71
360° View
360° View
42 56 48 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
56 49 56 48
Opinions Change
50 46 50 58
Pro Holdings
n/a 18 8 32
Market Pulse
59 75 87 90
Sentiment
29 49 55 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
98 8 8 25
Growth
41 59 100 31
Safety Safety
34 40 29 82
Combined
77 46 32 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
97 16 15 28
Price vs. Earnings (P/E)
100 1 12 2
Price vs. Book (P/B)
56 10 12 31
Dividend Yield
67 1 1 1
Value
98 8 8 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
72 98 98 76
Profit Growth
9 4 84 13
Capital Growth
94 72 85 33
Stock Returns
9 33 100 39
Growth
41 59 100 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
28 68 63 94
Refinancing
88 51 48 73
Liquidity
13 89 14 36
Safety Safety
34 40 29 82

Similar Stocks

Discover high‑ranked alternatives to Redcare Pharmacy and broaden your portfolio horizons.

Randstad

AEX:RAND
Country: Netherlands
Industry: HR- & Employment Services
Size: X-Large
Full Stock Analysis

STMicroelectronics

PAR:STMPA
Country: Netherlands
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Ternium

NYQ:TX
Country: Netherlands
Industry: Steel
Size: X-Large
Full Stock Analysis

Henkel

GER:HEN3
Country: Germany
Industry: Household Products
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews